 EXFORGE D
|
Siegfried
|
| valsartán+hidrocloroti.+amlodip. |
Antihipertensivo |
| 160/12.5/10 mg comp.x 28 | $61.385,94 | (11/02/26) |
| SIFAR |
Producto Reconocido |
|
| PAMI |
|
| AF $29.827,96 |
|
|
|
|
| 160/12.5/5 mg comp.x 28 | $61.975,57 | (11/02/26) |
| SIFAR |
Producto Reconocido |
|
| PAMI |
|
| AF $30.114,47 |
|
|
|
|
| 160/25/10 mg comp.x 28 | $61.975,57 | (11/02/26) |
| SIFAR |
Producto Reconocido |
|
| PAMI |
|
| AF $30.114,47 |
|
|
|
|
| 160/25/5 mg comp.x 28 | $61.975,57 | (11/02/26) |
| SIFAR |
Producto Reconocido |
|
| PAMI |
|
| AF $30.114,47 |
|
|
|
|
| 320/25/10 mg comp.x 28 | $65.542,64 | (11/02/26) |
| SIFAR |
Producto Reconocido |
|
| PAMI |
|
| AF $31.847,74 |
|
|
|
|
| |
